Palatin Technologies, Inc.
At Close: 4:00 PM
After Market: 3:03 AM
PTN Stock Price Graph
PTN Stock Price Today
Palatin Technologies, Inc. (PTN) stock declined over -5.66% intraday to trade at $1.5 a share on AMEX. The stock opened with a loss of -3.14% at $1.54 and touched an intraday high of $1.60, falling -5.66% against the last close of $1.59. The Palatin Technologies, Inc. in stock market went to a low of $1.47 during the session.
PTN Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
PTN Stock Price History Chart
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was incorporated in 1986 and is based in Cranbury, New Jersey.
Frequently Asked Questions
What is the current Palatin Technologies, Inc. (PTN) stock price?
Palatin Technologies, Inc. (AMEX: PTN) stock price is $1.50 in the last trading session. During the trading session, PTN stock reached the peak price of $1.60 while $1.47 was the lowest point it dropped to. The percentage change in PTN stock occurred in the recent session was -5.66% while the dollar amount for the price change in PTN stock was -$0.09.
PTN's industry and sector of operation?
The AMEX listed PTN is part of Biotechnology industry that operates in the broader Healthcare sector. Palatin Technologies, Inc. , a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States.
Who are the executives of PTN?
Mr. James E. Hattersley
Senior Vice President of Bus. Devel.
Mr. John Dodd Ph.D.
Senior Vice President of Preclinical Devel.
Dr. Carl Spana Ph.D.
Co-Founder, Pres, Chief Executive Officer & Director
Mr. Stephen T. Wills CPA, CPA, MST
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer & Sec.
How PTN did perform over past 52-week?
PTN's closing price is 0.03% higher than its 52-week low of $1.47 where as its distance from 52-week high of $6.8 is -0.79%.
How many employees does PTN have?
Number of PTN employees currently stands at 33.00. PTN operates from Cedar Brook Corporate Center, Cranbury, NJ 08512, US.
Link for PTN official website?
Official Website of PTN is: https://palatin.com
How do I contact PTN?
How many shares of PTN are traded daily?
PTN stock volume for the day was 101797.00 shares. The average number of PTN shares traded daily for last 3 months was 70.9 Thousands.
What is the market cap of PTN currently?
The market value of PTN currently stands at $29.08 Million with its latest stock price at $1.50 and 10.8 Million of its shares outstanding.